CytoDyn (STU:296) Buyback Yield %: 0.00 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:296 CytoDyn Inc STU:296
34 GF Score
Price €0.19
! 1 Warning Sign
View Full Analysis

What is CytoDyn Buyback Yield %?

CytoDyn STU:296 -3.03% 34 Buyback Yield % is 0.00 as of Jul. 19, 2026. GuruFocus rates STU:296 with a GF Score™ of 34/100. The stock has 1 warning sign investors should review. Among 740 Biotechnology companies, CytoDyn ranks worse than 135135% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

CytoDyn's current buyback yield was 0.00%.

CytoDyn Buyback Yield % Historical Data

* Premium members only.

The historical data trend for CytoDyn's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CytoDyn Buyback Yield % Chart

CytoDyn Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 -17.68 -10.76 -3.95 0.00

CytoDyn Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.91 0.00 0.00 0.00 0.00

STU:296 vs VSTM, IRD, PALI: Buyback Yield % Comparison

For the Biotechnology subindustry, CytoDyn's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CytoDyn Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CytoDyn's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where CytoDyn's Buyback Yield % falls into.


STU:296
34GF Score
CytoDyn Inc STU:296
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CytoDyn Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

CytoDyn's Buyback Yield for the fiscal year that ended in May. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 372.253852
=0.00%

CytoDyn's annualized Buyback Yield for the quarter that ended in Feb. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 285.17076
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
CytoDyn (STU:296) has a Buyback Yield % of 0.00 as of Jul. 19, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CytoDyn and its competitors. According to the industry distribution chart, CytoDyn ranks #999999 out of 740 companies in the Biotechnology industry.
Is CytoDyn's Buyback Yield % too high?
CytoDyn's current Buyback Yield % is 0.00. Based on the distribution chart, CytoDyn ranks #999999 out of 740 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CytoDyn has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does CytoDyn's Buyback Yield % compare to VSTM and IRD?
According to the Biotechnology industry distribution chart, CytoDyn ranks #999999 out of 740 companies for Buyback Yield %. This places CytoDyn in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CytoDyn and its competitors. CytoDyn's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CytoDyn stock overvalued right now?
CytoDyn (STU:296) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. CytoDyn's overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For CytoDyn (STU:296), the current Buyback Yield % is 0.00 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CytoDyn Business Description

Other Exchanges CYDY:USA
Address 1111 Main Street, Suite 660, Vancouver, WA, USA, 98660
CytoDyn Inc is a USA-based clinical-stage biotechnology company that focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The product candidate is PRO 140, which is a class of HIV therapy called entry inhibitors that block HIV from entering into and infecting certain cells. The company emphasizes exploring opportunities for clinical applications for PRO 140 involving the CCR5 (C-C chemokine receptor type 5) receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases, and cancer.
34GF Score

Get the complete analysis for STU:296

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.19
Price